Isatuximab is a medication that targets a specific protein called CD38 on the surface of multiple myeloma cancer cells. It is used to treat patients with multiple myeloma that has returned or stopped responding to previous treatments. It works by helping the immune system recognize and destroy cancer cells.

Pegenzileukin is an experimental medication designed to stimulate and enhance the immune system’s ability to fight cancer. It works by activating specific immune cells that can help combat multiple myeloma cells.

Dexamethasone is a steroid medication commonly used in multiple myeloma treatment. It helps reduce inflammation and can enhance the effectiveness of other cancer treatments. It also helps manage various symptoms associated with cancer and its treatment.

Multiple Myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that help fight infections. In this condition, abnormal plasma cells multiply uncontrollably in the bone marrow, forming tumors in multiple bones throughout the body. These cancerous cells interfere with the production of normal blood cells and can damage bones. The disease often causes bone pain, especially in the spine and ribs, and can lead to frequent infections, fatigue, and weakness. Multiple myeloma typically progresses gradually, with periods of active disease alternating with periods of remission.

Cancer – A disease characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells divide rapidly and can invade nearby tissues, potentially spreading to other parts of the body through the blood and lymph systems. Cancer cells develop due to damage or changes to DNA, which can be caused by various environmental and genetic factors. The disease can develop in almost any organ or tissue and typically forms solid tumors, except in blood cancers.